Novozymes A S DKK 2.0: which funds own it
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Sections with a free account
No concentrated manager holds it.
Who owns Novozymes A S DKK 2.0?
As of Jun 30, 2026, the largest holders reported on Form 13F were Delaney Dennis R (7,250 shares), Elefante Mark B (5,900 shares) and Kurt F Somerville (3,240 shares).
Which institutions hold the most Novozymes A S DKK 2.0 shares?
Per Form 13F filings as of Jun 30, 2026:
- 1. Delaney Dennis R: 7,250 shares
- 2. Elefante Mark B: 5,900 shares
- 3. Kurt F Somerville: 3,240 shares
- 4. Hemenway Trust: 3,196 shares
We hold 13D and 13G filings made since December 2024: a holder above 5% that has not filed since then does not appear here.
Quarter flow (concentrated managers)
Concentrated managers holding it
None in the latest quarter.
Largest holders (all 13F filers)
- Delaney Dennis R7,250Wealth adviser−2,500
- Elefante Mark B5,900Wealth adviser+2,500
- Kurt F Somerville3,240Wealth adviser−500
- Hemenway Trust3,196Wealth adviser+3,196
- Shares
- 7,250
- Change
- −2,500
See more
- Type
- Wealth adviser
- Value
- $456K
- Elefante Mark B
- Shares
- 5,900
- Change
- +2,500
See more
- Type
- Wealth adviser
- Value
- $371K
- Shares
- 3,240
- Change
- −500
See more
- Type
- Wealth adviser
- Value
- $204K
- Shares
- 3,196
- Change
- +3,196
See more
- Type
- Wealth adviser
- Value
- $201K
The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.
Insiders (Form 4)
Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.
Above 5% (13D/13G)
This list may be incomplete: we hold 13D and 13G filings made since December 2024. A holder above 5% that has not filed anything since then is not shown here.
No recent filings.
This company filed no 8-K forms in the last year. Foreign companies listed in the US (ADRs) report material events on forms 6-K and 20-F, and ETFs and funds do not file 8-Ks. If it is a foreign company listed in the US through ADRs (American Depositary Receipts), what trades are bank-issued certificates that represent shares from its home market.